LoboVault Home

The role of aryl hydrocarbon receptor in blood pressure regulation and vascular homeostasis


Please use this identifier to cite or link to this item: http://hdl.handle.net/1928/10358

The role of aryl hydrocarbon receptor in blood pressure regulation and vascular homeostasis

Show simple item record

dc.contributor.author Zhang, Nan
dc.date.accessioned 2010-02-09T22:14:27Z
dc.date.available 2010-02-09T22:14:27Z
dc.date.issued 2010-02-09T22:14:27Z
dc.date.submitted July 2009
dc.identifier.uri http://hdl.handle.net/1928/10358
dc.description.abstract High blood pressure and endothelial dysfunction are two systemic abnormalities of the cardiovascular system that extensively contribute to the etiology of cardiovascular diseases, which represent the number one killer in the United States for decades and become more severe in developing countries. Previous studies have indicated that aryl hydrocarbon receptor (AHR), a transcription factor primarily mediating xenobiotic metabolism, plays an important role in cardiovascular development and physiology. AHR deficient mice have been demonstrated to develop hypotension at sea level and oxygen-dependent, endothelin-1 (ET-1) mediated hypertension at mild altitude. However, after generations at mild altitude, AHR deficient mice appear to acclimate to the lower atmospheric partial pressure of oxygen and exhibit normal levels of ET-1 and hypotension. Therefore, the goal of my research was to elucidate the mechanism by which endogenous AHR regulates blood pressure by studying blood pressure regulation in the absence of the AHR. I found that AHR deficient mice exhibit significantly lower systemic arterial blood pressure, dysregulated circadian blood pressure rhythm, and significantly elevated vascular endothelial nitric oxide synthase (eNOS) expression and systemic production of nitric oxide (NO). I found that treating AHR deficient mice with the NOS inhibitor, Nω-nitro-L-arginine (LNNA) failed to normalize blood pressure, suggesting that vascular eNOS over expression may not be the primary mediating factor of hypotension in AHR knockout mice. Further investigation on vascular activity ex vivo indicated increased sensitivity of vascular smooth muscle to NO which may simultaneously contribute to the hypotension in this scenario. In vitro studies using human aortic endothelial cells with AHR expression knockdown by siRNA suggested an intracellular role of endogenous AHR signaling in suppressing eNOS mRNA expression, which could be normalized by exogenous ligand activation of the residual AHR. My results suggest that AHR suppresses eNOS expression and acts to maintain basal vascular tone and normal blood pressure. Therefore, therapeutic approaches that antagonize AHR signaling could improve NO bioavailability and benefit patients with hypertension and vascular diseases commonly associated with endothelial dysfunction. en_US
dc.language.iso en_US en_US
dc.subject aryl hydrocarbon receptor en_US
dc.subject blood pressure en_US
dc.subject endothelial nitric oxide synthase en_US
dc.subject.lcsh Cardiovascular system--Diseases--Etiology
dc.subject.lcsh Blood pressure--Regulation
dc.subject.lcsh Vascular endothelium--Pathophysiology
dc.subject.lcsh Xenobiotics--Metabolism--Regulation
dc.subject.lcsh Nitric oxide--Regulation
dc.subject.lcsh Transcription factors
dc.title The role of aryl hydrocarbon receptor in blood pressure regulation and vascular homeostasis en_US
dc.type Dissertation en_US
dc.description.degree Biomedical Sciences en_US
dc.description.level Doctoral en_US
dc.description.department University of New Mexico. Biomedical Sciences Graduate Program en_US
dc.description.advisor Walker, Mary
dc.description.committee-member Kanagy, Nancy
dc.description.committee-member Resta, Tom
dc.description.committee-member Timmins, Graham

Files in this item

Files Size Format View
Nan Zhang Ph.D. in Biomedical Sciences.pdf 1.297Mb PDF View/Open

This item appears in the following Collection(s)

Show simple item record

UNM Libraries

Search LoboVault


My Account